Dyadic International, Inc.

Stage 4 · Declining · week 5

As of Oct 22, 2026, Dyadic International is in Stage 4, the downtrend phase, now in week 5 (since Sep 21, 2026). It closed at $0.40, 72.8% below its 52-week high and below its 200-day average, which is falling.

$0.40

+0.00% today

$16.1M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is DYAI early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 20w

S4 15w

S4 22w

S4 32w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S3 7w → S2 3w → S3 2w → S4 20w → S1 8w → S2 6w → S3 5w → S4 15w → S1 6w → S2 7w → S3 8w → S4 22w → S1 10w → S4 32w → S1 2w → S2 5w → S3 2w → S4 5w current

Total tracked: 165 weeks across 18 stage runs.

DYAI among Biotechnology407th of 591 by relative strength

All 591 →

Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	GTBPGT Biopharma, Inc.	Stage 2 · wk 7	99	−22.3%
2	IOVAIovance Biotherapeutics, Inc.	Stage 2 · wk 18	99	+38.8%
3	SLSSELLAS Life Sciences Group, Inc.	Stage 3 · wk 4	99	−1.5%
4	MRNAModerna, Inc.	Stage 2 · wk 17	99	+11.3%
5	TWSTTwist Bioscience Corporation	Stage 2 · wk 39	99	−14.5%
6	KODKodiak Sciences Inc	Stage 2 · wk 4	99	+172.1%
7	ERASErasca, Inc.	Stage 3 · wk 5	99	+0.7%
8	CLYMClimb Bio, Inc.	Stage 3 · wk 3	99	−15.8%
…407	DYAIDyadic International, Inc.	Stage 4 · wk 5	17	−2.4%

vs 52W High

-72.8%

$0.38 lo$1.47 hi

72.8% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 5

1w13w26w

Week 5, early Stage 4 decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-48.6%

200 DMA: $0.78 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.25x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-2.4%

-66.4%

-54.0%

YTD

-57.4%

-64.0%

Scan Membership

Breakout Watch

Latest: 2025-01-07

9 appearances in last 60 days. First seen: 2018-10-16.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 5 · Vol 0.25x

2026-10-21S4

Wk 5 · Vol 0.37x

2026-10-20S4

Wk 5 · Vol 0.32x

2026-10-19S4

Wk 5 · Vol 1.07x

2026-10-16S4

Wk 4 · Vol 0.43x

2026-10-15S4

Wk 4 · Vol 2.82x

2026-10-14S4

Wk 4 · Vol 0.20x

2026-10-13S4

Wk 4 · Vol 0.26x

2026-10-12S4

Wk 4 · Vol 0.18x

2026-10-09S4

Wk 3 · Vol 0.06x

2026-10-08S4

Wk 3 · Vol 0.64x

2026-10-07S4

Wk 3 · Vol 0.65x

Moving averages & range

50 DMA

$0.51

200 DMA

$0.78

52W High

$1.47

52W Low

$0.38

5D Low

$0.38

Resistance levels (recent highs)

20d High

$0.47

60d High

$1.08

120d High

$1.47

250d High

$1.47

Next resistance

+17.5%

to 20d High

Dividend Yield

0.00%

P/B -6.1

Dyadic International: quick answers

What stage is Dyadic International in?

As of Oct 22, 2026, Dyadic International (DYAI) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 21, 2026 and is in week 5. What the four stages mean

Is Dyadic International in an uptrend?

No. Dyadic International is in a Stage 4 downtrend. It trades 48.6% below its 200-day average, which is falling.

How far is Dyadic International from its 52-week high?

Dyadic International closed at $0.40 on Oct 22, 2026, 72.8% below its 52-week high of $1.47. Its 52-week low is $0.38.

How has Dyadic International performed over the past year?

As of Oct 22, 2026, Dyadic International is down 64.0% over the past year and down 57.4% so far in 2026.

Which sector and industry is Dyadic International in?

Dyadic International is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases; and collaboration with Scripps Research to evaluate monoclonal antibody and vaccine candidates targeting hantaviruses. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.